OpenCharities

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator.

PDF
Markdown

2023-09-30-accounts

		Page
Contents		Numbers
Legal and administrative	information
Report ofthe Trustees		3-10
Report ofthe Auditors		11-13
Statement offinancial	activities	14
Charity balance sheet		15
Notes forming part ofthe financial statements		16-25

Charity registration	Charity registration	number: 1129597	number: 1129597	number: 1129597
Company	registration		number: 6876186
Directors	and
Trustees:			Dr Kevin Moreton			24/11/15 —present
			DrJan Lowe			17/05/18- present
			Dr Liz Miller			13/08/18 —present
			Dr LeoJames			28/03/19 —present
			Dr Anne Bertolotti			05/11/20- present
Secretary:			Mrs Josie Gowler	FCA		18/04/18 —present
Registered			MRC Laboratory of Molecular		Biology
Office:			Francis Crick Avenue
			Cambridge Biomedical Campus
			Cambridge
			CB2 OQH
Auditors:			Price Bailey LLP:
			Tennyson House
			Cambridge Business Park
			Cambridge
			CB4OWZ
Bankers:			Lloyds Bank PLC:
			3Sidney Street
			Cambridge
			CB2 3BL)
Solicitors:			HCR Legal LLP:
			50-60Station Road
			Cambridge
			CB12JH

						Total Year	Total Year
					Expendable	01/10/22	01/10/21
			Unrestiicted	Restricted	Endowment	to	to
			Funds	Funds	Funds	30/09/23	30/09/22
		Note	E	E	E	E	E
In«ome:
Donations and legacies
Donations			86,264	0	0	86,264	64,207
Grants Received			0	70,159	0	70,159	0
Investment Income		4	104,251	52,680	19,166	176,097	155,006
Trading income		14	179	0	0	179	172
Total Income				122,839
Expenditure on:
Charitable Activities			78,560	101,421		179,981	92,761
Trading Activities			0	0		0	3
Total Expenditure		5	78,560	101,421		»9,9Sl
Net Gains/(Losses)
on Investments			72,653	36,863	13,412	122,928	(344,701)
Net (Expenditure)	/
Income			184,787	58,281	32,578	275,646	(218,080)
Transfers between	funds
Net movement in	funds		184,787	58,281	32,578	275,646	(218,080)
Fund Balances
brought forward at
01October 2022			1,878,611	987,466	347,895	3,213,972	3,432,052
Fund Balances
carried forward at
30September 2023							3,»,9

					30/09/2023	30/09/2022
				Notes	E	E
Fixed Assets
Investments					2,975,034	2,852,106
TOTAL FIXEDASSETS					2,975,034	2,852,106
Current Assets
Debtors: amounts	falling		due within one year	10	18,108	560
Cash at bank and in		hand			515,277	382,021
TDTALCURRENTASSETS					533,385	382,581
Creditors: amounts		falling due within one year			(18,801)	(20,715)
Net current assets					514,584	361,866
Net Assets
Funds ofthe charity
Unrestricted Funds
General Funds					1,181,833	1,020,607
Designated Funds					881,565	858,005
					2,063,398	1,878,612
Restricted Funds
Restricted Funds					1,045,747	987,466
Expendable Endowment			Funds		380,473	347,894
					1,426,220	1,335,360
Total Funds				12	3,489,618

		Total forthe	Total forthe
		Year	Year
		01/10/2022 to	01/10/2021 to
		30/09/2023	30/09/2022
		E
Individuals		65,651	10,641
Gift Aid		15,613	560
Corporate	Donors	0	53,006
Trusts		5,000	0
			64,207

		Total for the	Total forthe
		Year	Year
		01/10/2022 to	01/10/2021to
		30/09/2023	30/09/2022
		E	E
Interest Receivable		426	8
Dividends	received from Investments	175,671	154,998

				Activites	Grant	Support
				Undertaken	funding of	Costs	Total
				Dire*ly	a*ivities	(Note 6)	Funds
				E	E	E	E
Promotion	and advancement		of
education	and research			47,924	123,640	8,417	179,981
Trading activities				0	0	0	0
				47,924	123,640	8,417	179,981
Analysis ofExpenditure		-Prior Year
				Activites	Grant	Support
				Undertaken	funding of	Costs	Total
				Directly	activities	(Note 6)	Funds
				6	E	E	E
Promotion	and advancement		of
education	and research			44,499	40,317	7,945	92,761
Trading activities				3	0	0	3
				~84 819	40,317

Analysis of	Support Costs	Support Costs
							Total for the	Totalforthe
							Year	Year
							01/10/2022 to	01/10/2021 to
							30/09/2023	30/09/2022
							E	E
Professional	Fees						1,680	1,621
8ank Fees							160	168
Trustee Indemnity Insurance							264	967
Accountancy	Services						13	13
Governance	Costs (See note			7)			6,300	5,176
							8,417
Analysis of	Governance Costs
							Totalforthe	Totalforthe
							Year	Year
							01/10/2022 to	01/10/2021to
							30/09/2023	30/09/2022
							E	E
Audit Fees							6,300	5,176
Trustees' remuneration
The trustees	received	no emoluments			or reimbursed	expenses during the year (2022- ENil).
During the year, insurance			was purchased to indemnify				the Trustees against default on their part. The cost
ofthe insurance amounted				to 6264 (2022 - 6967).
Fixed asset	investments
							Totalforthe	Totalforthe
							Year	Year
							01/10/2022 to	01/10/2021 to
							30/09/2023	30/09/2022
							E	E
Market value as at 1st		October					2,852,106	2,896,807
Additions							0	300,000
Disposal Proceeds							0	0
Net investments gains		/ (losses)					122,928	(344,701)
Market value as at 30th September							2,975,034	2,852,106
Historical cost as at 30th September							2,590,854	2,590,854
UK listed investments		are	represented		by:
Investment	trusts and	unit	trusts				2,975,034	2,852,106
							2,975,034	2,852,106

							Totalforthe	Total for the
							Year	Year
							01/10/2022to	01/10/2021 to
							30/09/2023	30/09/2022
								E
Gift aid		accrued income					15,613	560
Prepayments							2,495	0
							18,108
ll Creditors: amounts			falling due within	one year
							Total for the	Total for the
							Year	year
							01/10/2022to	01/10/2021 to
							30/09/2023	30/09/2022
							6	6
Accrue		Is					18,801	20,715
12a Statement of Funds			- current year
							Investment
			At			Transfers	Gains/	At
			01/10/2022	Income	Expenditure	In/Out	(Losses)	30/09/2023
			6	6	E	E	6	F.
GeneralFund			1,020,607	144,995	(25,429)		41,660	1,181,833
Oesignated	Funds
Perutz Fund			312,110	18,599	(1,500)		12,029	341,238
Milstein Fund			522,649	26,081	(49,245)		18,251	517,735
AstraZeneca
Lecture Series			20,882	1,019	(2,386)		713	20,228
Michael
iseuberger
Studentship			2,364					2,364
Total
Unrestricted		funds	1,878,611	190,694	(78,560)		72,653	2,063,398
Restrkted funds
Steitz (formerly Brenner)
Postdoc Pdze			27,673	327	(21,733)		229	6,496
Sangamo Aaron King
Symposium			3,588	0	(3,588)			0
GSA/PAL Fund			2,192	10	(2,014)			195
Fidelity Bermuda			0	70,159	(70,159)			0
Jeantet
Ramakdshnan			343,204	18,692	(3,927)		13,079	371,048
Jeantet Winter			610,809	33,651	0		23,548	668,008
			987,466	122,839	(101,421)		36,863	1,045,747
Expendable
Endowments
Agouron			240,758	13,264			9,282	263,304
Grigg Fund			107,137	5,902			4,130	117,169
			347,895	19,166			13,412	380,473
Total
restricted funds			1,335,360	142,005	(101,421)		50,275	1,426,220
Totalfunds			3,213,972	332,699	(179,981)		122,928	3,489,618

							Investment
			At			Transfers	Gains/	At
			01/10/2021	Income	Expenditure	ln/Out	(Losses)	30/09/2022
			E	E	E	E	E	E
General Fund			1,096,930	57,084	(23,866)		(109,541)	1,020,607
Designated	Funds
Perutz Fund			331,290	15,819	(1,500)		(33,499)	312,110
Milstein Fund			597,302	25,224	(43,781)		(56,096)	522,649
AstraZeneca
Lecture Series			3,876	21,008	(1,761)		(2,241)	20,882
Michael
Neuberger
Studentship			2,067	297	0			2,364
Total
Unrestricted	funds			119,432	(70,908)		(201,377)	1,878,611
Restricted funds
Steitz (formerly		Brenner)
Postdoc Prize			11,138	34,341	(14,836)	0	(2,970)	27,673
Sangamo Aaron		idug
Symposium			10,497	173	(6,697)		(385)	3,588
GSA/PAL Fund			0	2,606	(178)		(236)	2,192
Jeantet
Ramakrishnan			363,621	16,564	(145)	0	(36,836)	343,204
Jeantet Winter			646,888	29,479	0	0	(65,558)	610,809
			1,032,144	83,163	(21,856)	0	(105,985)	987,466
Expendable
Endowments
Agouron			254,979	11,619		0	(25,840)	240,758
Grigg Fund			113,464	5,171		0	(11,499)	107,137
			368,443	16,790		0	(37,339)	347,895
Total
restdcted funds			1,400,588	99,953	(21,856)	0	(143,324)	1,335,360
Totalfunds			3,432,052	219,385	(92,764)	0	i,70 i	3.2 3.9»